VitriVax $17.25M Sales Trigger Playbook

🚀 Battle Card: VitriVax

• Romulo Colindres, CEO 📧 RColindres@vitrivaxbio.com

• This VitriVax sales trigger highlights fresh capital to accelerate thermostable vaccine development and expand global accessibility. → Source

• Cold‐chain logistics gaps hindering distribution to remote regions

• Scale-up complexities in manufacturability of novel formulations

• Primary: Scalable biomanufacturing platform → Faster time-to-market & reduced CapEx

• Expansion: Regulatory compliance analytics → Streamlined approvals & audit readiness

• HQ: Boulder, CO

• Employees: ≈ 50

• Rev: ≈ $8M

• Website: vitrivaxbio.com

🤼 Competitive Intel

• Veeva Systems — CRM for life sciences
• Unique edge: Industry-specific compliance & data models
• Evaluated by VP Sales for regulatory-aligned CRM

• Salesforce — Health Cloud & CRM
• Unique edge: Scalable, AI-driven lead management
• Evaluated by Sales Ops for integration

• Thermo Fisher Scientific — Formulation & fill/finish
• Unique edge: End-to-end pharma services
• Evaluated by Head of Product for scalability

• Lonza — CDMO & biologics manufacturing
• Unique edge: Global network & cell therapy expertise
• Evaluated by CTO for capacity & quality

• Catalent — Biologics development & delivery
• Unique edge: Advanced delivery tech & regulatory support
• Evaluated by VP Ops for time-to-market

✅ Do-Now Checklist

Next Step

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑≈ TBD❑
OFFER_BRIEF   = ❑Scalable biomanufacturing platform❑
PROOF_METRIC  = ❑30% CapEx reduction❑
CTA_STYLE     = ❑quick_call❑
TONE          = ❑punchy❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = Romulo
COMPANY     = VitriVax
DEPT        = Manufacturing
SIZE        = 50
BOTTLENECK  = cold-chain logistics gaps
EVENT       = Series B financing
DETAIL      = raised $17.25M in Series B financing
PAIN        = cold-chain logistics hindering distribution
SRC         = https://vcnewsdaily.com/vitrivax/venture-capital-funding/fzfcxwnswt
SIM_CO      = Lonza
WIN_METRIC  = 40% faster scale-up
NEXT_SIZE   = 100
EMP_EST     = ≈ 50
REV_EST     = ≈ $8M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.

Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: 50-person Manufacturing

Romulo—noticed your Manufacturing team is ≈ 50.

That’s when cold-chain logistics gaps slows growth.

We helped Lonza fix this with Scalable biomanufacturing platform.

Result: 40% faster scale-up.  
Quick call?

PS—next bottleneck hits ≈ 100.

DM ≤45 words, TONE:
Saw your post about raised $17.25M in Series B financing — cold-chain logistics hindering distribution.  
Scalable biomanufacturing platform. 30% CapEx reduction.  
Quick chat?